What international patients should know
Fertility treatment is one of the most sensitive and highly regulated areas of healthcare. For international patients, China can be a serious fertility option because it has large reproductive medicine centers, experienced fertility teams, advanced laboratory systems, and a national regulatory framework for assisted reproductive technology. But China is not suitable for every fertility case. Before considering fertility treatment in China, international patients must understand: MedVoyage China helps international patients understand the pathway before they make travel or treatment decisions.
- who may be eligible
- which services are legally permitted
- which services are not allowed
- what documents are required
- how success rates are reported
- how long the process may take
- whether treatment requires in-person visits
- which hospital or city is suitable
Why Consider Fertility Treatment in China?
International patients may consider China for fertility care because of: China’s fertility system is large and clinically experienced, but access is not automatic. Eligibility must be confirmed case by case by approved medical institutions.
- large reproductive medicine centers
- high patient volume
- experienced fertility specialists
- regulated assisted reproductive technology
- IVF, ICSI, and PGT capabilities in approved institutions
- strong hospitals in Beijing, Shanghai, Guangzhou, Shenzhen, Chengdu, and other cities
- lower cost structure for selected services compared with many private fertility systems overseas
- access to broader medical evaluation where needed
- Chinese-speaking family support for overseas Chinese patients
- possibility of combining fertility evaluation with other healthcare services
China’s Assisted Reproductive Medicine System
China’s assisted reproductive medicine system is regulated by government authorities. International patients should only consider properly approved institutions. MedVoyage can help patients understand how to check whether an institution is approved and what type of assisted reproductive technology it is allowed to provide.
What Fertility Services May Be Available in China?
Availability depends on the institution’s approval scope, patient eligibility, medical indication, and Chinese law. Potential fertility-related services may include: The exact service must be confirmed by an approved fertility institution. MedVoyage does not determine eligibility or treatment plan. Hospitals and qualified fertility specialists make those decisions.
- fertility evaluation
- reproductive endocrinology consultation
- ovarian reserve testing
- semen analysis
- ultrasound
- ovulation assessment
- fallopian tube evaluation
- intrauterine insemination where legally and medically appropriate
- IVF
- ICSI
- embryo culture
- frozen embryo transfer
- PGT where medically indicated and legally permitted
- fertility-related minimally invasive surgery
- reproductive genetics consultation where appropriate
Important Legal and Ethical Restrictions in China
This section is essential. International patients must understand that China has strict rules for assisted reproductive technology.
Surrogacy Is Prohibited
China prohibits any form of surrogacy. MedVoyage cannot assist with surrogacy requests in China.
Non-Medical Sex Selection Is Prohibited
China prohibits non-medical sex selection. PGT or reproductive genetic testing must follow medical indications and legal requirements. MedVoyage cannot assist with non-medical sex selection requests.
Assisted Reproductive Technology Must Be Used for Medical Purposes
China’s assisted reproductive technology rules require medical purpose, ethical review, and compliance with law and regulation. Patients must meet hospital and legal eligibility requirements.
Eligibility Must Be Confirmed by the Hospital
Eligibility may involve: Requirements may vary by institution and case. International patients should not travel before eligibility and documents are clarified.
- marital status
- identity documents
- marriage documents
- medical indication
- reproductive history
- age
- ovarian reserve
- semen analysis
- infectious disease screening
- genetic risk assessment
- hospital review
Egg Donation and Sperm Bank Use Are Strictly Regulated
Egg donation is highly restricted and commercialized egg donation is prohibited. Sperm bank services are also regulated. Foreign patients must confirm whether any donor-related service is legally available and medically appropriate.
Who May Be Suitable for Fertility Evaluation in China?
Fertility evaluation in China may be relevant for: Suitability must be confirmed by an approved fertility institution.
- married heterosexual couples with infertility concerns
- couples with repeated IVF failure
- couples with recurrent miscarriage
- couples with male-factor infertility
- couples with tubal factor infertility
- couples with ovulation disorders
- couples needing ovarian reserve evaluation
- couples considering IVF or ICSI
- couples with medically indicated genetic risk requiring specialist review
- overseas Chinese couples who want care in a Chinese-speaking environment
- couples seeking a second opinion on fertility treatment
Who Is Not Suitable Under China’s Current Rules?
China may not be suitable for patients seeking: MedVoyage will not assist with requests that violate Chinese law or medical ethics.
- surrogacy
- non-medical sex selection
- fertility treatment without meeting legal eligibility requirements
- commercial egg donation
- services not permitted by Chinese law
- guaranteed embryo selection for non-medical reasons
- treatment that does not have medical indication
Success Rates: How to Understand the Data
Fertility success rates are difficult to compare across countries and institutions. Patients should be careful. Some hospitals report: These are not the same. Clinical pregnancy rate is not the same as live birth rate. Before choosing a fertility pathway, patients should ask:
- clinical pregnancy rate
- live birth rate
- embryo implantation rate
- age-specific success rate
- fresh cycle success rate
- frozen embryo transfer success rate
- PGT success rate
- cumulative live birth rate
- Is the rate clinical pregnancy rate or live birth rate?
- Is it age-specific?
- Is it for fresh transfer or frozen transfer?
- Is it per cycle, per transfer, or cumulative?
- Does it include patients with similar age and diagnosis?
- Does it apply to international patients?
- What are the risks and limitations?
How Long Does Fertility Treatment in China Take?
Timing depends on the case, treatment type, documents, and hospital requirements. A fertility evaluation may be shorter. An IVF cycle may require weeks. A full process may take months, especially if it includes: International patients may need to travel to China more than once.
- preliminary testing
- cycle scheduling
- ovarian stimulation
- egg retrieval
- sperm preparation
- fertilization
- embryo culture
- embryo transfer
- embryo freezing
- PGT where medically indicated
- follow-up blood tests
- ultrasound confirmation
- additional cycles if needed
What Documents May Be Required?
Requirements vary by hospital and patient situation. International patients may need:
- passports
- valid visa or entry documents
- marriage certificate
- notarized or translated marriage certificate if required
- previous fertility records
- previous IVF records
- ovarian reserve tests
- semen analysis
- ultrasound results
- hormone tests
- infectious disease screening
- genetic testing reports if any
- previous miscarriage records
- previous surgery records
- medication list
- medical history
- consent forms
- hospital-specific documents
Cost of Fertility Treatment in China
Fertility treatment costs vary by city, hospital, treatment type, medication protocol, laboratory procedure, genetic testing, freezing, storage, and repeat cycles. Selected healthcare services in China may cost around 20%–50% of comparable prices in the US or Europe, depending on procedure, institution, materials, medication, testing, and complexity. This is not a guaranteed discount. Fertility treatment must be quoted case by case.
